DENYSE GALLAGHER: Open Payments
NPI 1588075055 · SOMERS POINT, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,781 in 89 payments from 25 companies in 2025. Trend: 2023 $1,472 · 2024 $2,143 · 2025 $1,781
Food & beverage: $1,781
| Company | Payments | Amount |
|---|---|---|
| Insulet Corporation | 13 | $353 |
| Abbott Laboratories | 18 | $178 |
| Novo Nordisk Inc | 9 | $140 |
| Madrigal Pharmaceuticals | 5 | $116 |
| Xeris Pharmaceuticals, Inc. | 2 | $114 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $103 |
| Tandem Diabetes Care, Inc. | 3 | $101 |
| Lilly USA, LLC | 4 | $69 |
| TOLMAR, INC. | 4 | $66 |
| BETA BIONICS, INC. | 3 | $64 |
Products named: Omnipod, FREESTYLE LIBRE 3, REZDIFFRA, Kerendia, t:slim X2 Insulin Pump with Control-IQ, GVOKE HYPOPEN, Ozempic, JATENZO.
Industry payments across NJ — which companies pay providers there.
